NVDA

207.05

+3.04%↑

AVGO.US

386.07

+3.57%↑

TSM

305.33

+1.18%↑

ORCL

275.25

-1.92%↓

ASML.US

1,070.7

+1.78%↑

NVDA

207.05

+3.04%↑

AVGO.US

386.07

+3.57%↑

TSM

305.33

+1.18%↑

ORCL

275.25

-1.92%↓

ASML.US

1,070.7

+1.78%↑

NVDA

207.05

+3.04%↑

AVGO.US

386.07

+3.57%↑

TSM

305.33

+1.18%↑

ORCL

275.25

-1.92%↓

ASML.US

1,070.7

+1.78%↑

NVDA

207.05

+3.04%↑

AVGO.US

386.07

+3.57%↑

TSM

305.33

+1.18%↑

ORCL

275.25

-1.92%↓

ASML.US

1,070.7

+1.78%↑

NVDA

207.05

+3.04%↑

AVGO.US

386.07

+3.57%↑

TSM

305.33

+1.18%↑

ORCL

275.25

-1.92%↓

ASML.US

1,070.7

+1.78%↑

Kodu・Aktsiate loetelu・Marqeta Inc (Class A)

Marqeta Inc (Class A)

Avatud

SektorTehnoloogia

4.53 -2.79

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.5600000000000005

Max

4.72

Põhinäitajad
By Trading Economics
Sissetulek	7.6M -647K
Müük	11M 150M
P/E Sektori keskmine	56.3 75.654
Kasumimarginaal	-0.43
Töötajad	854
EBITDA	11M -2.6M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+35.76% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. nov 2025

Turustatistika
By TradingEconomics
Turukapital	-597M 2B
Eelmine avamishind	7.32
Eelmine sulgemishind	4.53

Uudiste sentiment

By Acuity

50%

185 / 407 Pingereas Technology

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

3.975 / N/A Toetus ja vastupanu

Marqeta Inc (Class A) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. okt 2025, 23:50 UTC

Kuumad aktsiad

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28. okt 2025, 23:25 UTC

Tulu

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28. okt 2025, 23:18 UTC

Tulu

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28. okt 2025, 22:20 UTC

Tulu

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28. okt 2025, 22:13 UTC

Tulu

Wal-Mart de Mexico Net Profit Falls in 3Q

28. okt 2025, 21:38 UTC

Tulu

Correction to Visa Sales Jump Article

28. okt 2025, 21:17 UTC

Tulu

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28. okt 2025, 21:07 UTC

Tulu

Visa Sales Jump as Consumers Keep Spending -- Update

28. okt 2025, 21:02 UTC

Tulu

Mondelez Tempers Outlook as Costs Rise

28. okt 2025, 23:51 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28. okt 2025, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28. okt 2025, 23:02 UTC

Tulu

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28. okt 2025, 23:01 UTC

Tulu

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28. okt 2025, 22:46 UTC

Tulu

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28. okt 2025, 22:45 UTC

Tulu

SK Hynix 3Q Net KRW12.6T >000660.SE

28. okt 2025, 22:44 UTC

Tulu

SK Hynix 3Q Rev KRW24.44T >000660.SE

28. okt 2025, 22:43 UTC

Tulu

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28. okt 2025, 22:42 UTC

Tulu

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28. okt 2025, 22:40 UTC

Tulu

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28. okt 2025, 22:40 UTC

Tulu

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28. okt 2025, 22:22 UTC

Tulu

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28. okt 2025, 22:22 UTC

Tulu

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28. okt 2025, 22:22 UTC

Tulu

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28. okt 2025, 22:20 UTC

Tulu

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28. okt 2025, 22:02 UTC

Tulu

Review & Preview: Earnings Extravaganza -- Barrons.com

28. okt 2025, 21:42 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

28. okt 2025, 21:42 UTC

Market Talk

Tulu

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28. okt 2025, 21:20 UTC

Tulu

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28. okt 2025, 21:19 UTC

Tulu

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28. okt 2025, 21:18 UTC

Tulu

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Võrdlus sarnastega

Hinnamuutus

Marqeta Inc (Class A) Prognoos

Hinnasiht

By TipRanks

35.76% tõus

12 kuu keskmine prognoos

Keskmine 6.34 USD 35.76%

Kõrge 8 USD

Madal 5 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Marqeta Inc (Class A) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

9 ratings

Osta

Hoia

Müü

Põhineb 9 analüütiku instrumendi Marqeta Inc (Class A) aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

3.975 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

185 / 407 Pingereas Tehnoloogia

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Marqeta Inc (Class A)

Marqeta, Inc. operates a cloud-based open application programming interface platform that delivers card issuing and transaction processing services. It offers its solutions in various verticals, including financial services, on-demand services, expense management, and e-commerce enablement, as well as buy now, pay later. Marqeta, Inc. was incorporated in 2010 and is headquartered in Oakland, California.